SCHEMBL21252159

SCHEMBL21252159

COc1cc(OC)c(Cl)c(-c2cc3cnc(Nc4c(C)cccc4NC=O)nc3s2)c1Cl

nearest known ligand 0.51

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 14/20 0.51
▸ FGFR1 P11362 13/20 0.51
▸ FGFR2 P21802 3/20 0.51
▸ FGFR3 P22607 3/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CSF1R P07333 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21252041 0.86 FGFR4 (0.51) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL29578249 0.86 FGFR1 (0.71) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL20330933 0.86 FGFR1 (0.71) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL21321237 0.85 FGFR1 (0.53) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL24488260 0.84 FGFR1 (0.51) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL21251765 0.79 FGFR4 (0.56) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL21252089 0.78 FGFR1 (0.54) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL21252103 0.76 FGFR1 (0.58) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL21251981 0.73 FGFR4 (0.53) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL20330944 0.72 FGFR1 (0.71) FGFR4FGFR1FGFR2FGFR3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-A1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2019-08-14 — — EP disclosed
Send feedback